Načítá se...
Autocrine motility factor and its receptor expression in musculoskeletal tumors
Management of aggressive malignant musculoskeletal tumors is clinically challenging and awaits the identification of regulator(s) that can be therapeutically used to improve patient outcome. Autocrine motility factor (AMF), a secreted cytokine, is known to alter the bone microenvironment by linking...
Uloženo v:
| Vydáno v: | J Bone Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7574284/ https://ncbi.nlm.nih.gov/pubmed/33101887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2020.100318 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|